STOCK TITAN

Hoth Therapeutics, Inc. (HOTH) EPS by Year

HOTH

Hoth Therapeutics, Inc. lost $0.90 per diluted share in fiscal year 2025. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Hoth Therapeutics, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.90
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HOTH EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20FY19FY18
EPS (Diluted)-$0.90-$1.28-$2.38-$9.50+40.7%-$16.02N/AN/AN/A

HOTH EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'24Q4'23Q3'23Q2'23
EPS (Diluted)-$0.17+37.0%N/A-$0.30-$0.17-$0.27N/A-$0.32-$0.25-$0.49N/A-$0.63-$0.57

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Hoth Therapeutics, Inc. financials

Frequently Asked Questions

What was Hoth Therapeutics, Inc.'s diluted earnings per share in fiscal year 2025?

Hoth Therapeutics, Inc. lost $0.90 per diluted share in fiscal year 2025.

What was Hoth Therapeutics, Inc.'s diluted earnings per share in the most recent quarter?

Hoth Therapeutics, Inc. (HOTH) reported -$0.17 in diluted earnings per share in Q1 2026. This represents an increase of 37.0% from the same quarter a year earlier.

What does diluted earnings per share mean on a financial statement?

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Hoth Therapeutics, Inc. (HOTH) reported on that line in every period on record.